Sunday, December 18, 2011

India State FDA Files Complaint against DePuy with Mumbai Police

excerpts from a post on Rottenstein Law group's site

State Food and Drug Administration Asks Recipients to Step Forward

Mumbai—formerly called Bombay—is an Indian commercial metropolis located on the county’s west coast in the state of Maharashtra. According to an article in Daily News & Analysis, the state’s Food and Drug Administration (FDA) filed a complaint with the Mumbai police against DePuy. The primary problem for Indian authorities is that they don’t know how many people in their country received the hip replacements, though the article suggests 4,700 implants were sold there. Few Mumbai residents, however, appear to have received one, so the police are asking residents to step forward and report if they are among them.

One FDA official stated, “The Police are investigating. Once the implant recipients come forward, we will know how many are affected, and accordingly take action against the company.”

Indian Orthopedists React

As soon as the DePuy hip recall began in August 2010, orthopedists in Mumbai claim they immediately ceased using the ASR. One also said that until now, no one has reported hip replacement problems, and tests have not shown symptoms of metal poisoning. Although no one has undergone revision surgery of an ASR, some have received care for parts loosening or wearing out. As in the United States and elsewhere, DePuy has promised to reimburse recipients up through revising a failed implant.

No comments:

Post a Comment